Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MV-NIS Infected Mesenchymal Stem Cells in Recurrent Ovarian Cancer
NCT02068794Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- Mar 2024
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of MV-NIS in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Mayo Clinic. Started Apr 2014; status: active, not recruiting.
02
Drugs
MV-NIS
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT02068794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068794.